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Abstract
Background: Bone morphogenetic proteins (BMPs) were first described for their roles in bone formation, but they
now also are known to possess additional activities, including those relating to embryogenesis. The objectives of
this work were to 1) determine if peri-attachment bovine conceptuses and bovine trophoblast cells (CT1) contain
transcripts for BMP2 and 4, an innate inhibitor noggin (NOG), and BMP2/4 receptors (BMPRII, ACVR1, BMPR1A,
BMPR1B), and 2) determine if BMP2 or 4 supplementation to CT1 cells affects cell proliferation, differentiation or
trophoblast-specific gene expression.
Methods: RNA was isolated from day 17 bovine conceptuses and CT1 cells. After RT-PCR, amplified products were
cloned and sequenced. In other studies CT1 cells were treated with BMP2 or 4 at various concentrations and
effects on cell viability, cell differentiation and abundance of IFNT and CSH1 mRNA were evaluated.
Results: Transcripts for BMP2 and 4 were detected in bovine conceptuses and CT1 cells. Also, transcripts for each
BMP receptor were detected in conceptuses and CT1 cells. Transcripts for NOG were detected in conceptuses but
not CT1 cells. Cell proliferation was reduced by BMP4 but not BMP2 supplementation. Both factors reduced IFNT
mRNA abundance but had no effect on CSH1 mRNA abundance in CT1 cells.
Conclusions: The BMP2/4 ligand and receptor system presides within bovine trophectoderm prior to uterine
attachment. BMP4 negatively impacts CT1 cell growth and both BMPs affect IFNT mRNA abundance.
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Background
Bone morphogenetic proteins (BMPs) are part of the
transforming growth factor-b (TGFb)s u p e r f a m i l yo f
paracrine factors [1,2]. The BMPs mediate various phy-
siological and developmental processes, including pla-
cental development [3]. The BMP4 family of factors,
which include BMPs 2 and 4, appear to be especially
important in placental development. In the mouse, con-
ceptuses lacking BMP4 undergo developmental arrest at
days 6.5-9.5 and lack mesoderm and placental vascula-
ture [4-6]. Mesoderm formation also is absent in mice
lacking Bmpr2, the Type II receptor for BMP4 [7].
I n t e r e s t i n g l y ,B m p r 2n u l lm i c eh a v eam o r es e v e r ep h e -
notype than mice lacking BMP4, suggesting the partial
rescue of the BMP4 null phenotype by other BMPs,
such as BMP2 [8].
Bone morphogenetic proteins 2 and 4 also regulate
trophoblast lineage development and differentiation.
Trophoblast development from human embryonic stem
cells is induced by BMP2 and 4 [9,10]. In cattle, BMP4
supplementation improves the formation of trophoblast
cell outgrowths from blastocysts [11]. Moreover, tropho-
blast cell lines generated from these outgrowths produce
a multitude of factors, including interferon-tau (IFNT),
the maternal recognition of pregnancy factor in rumi-
nants that is secreted from mononucleated cells (MNCs)
before placental attachment to the uterine lining [12].
Some of the cell lines derived by BMP4 treatment con-
tain large quantities of IFNT mRNA whereas other lines
contain little IFNT and instead contain greater quanti-
ties of transcripts detected in differentiated, binucleate
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unclear if BMP4 may promote trophoblast cell differen-
tiation during culture.
The overall goal of this work was to describe the
expression and potential actions of the BMP4 ligand-
receptor system during the pre- and peri-attachment
period of bovine conceptus development. In the first set
of studies, transcript patterns were determined for
BMP2, BMP4,n o g g i n( NOG; a BMP2/4 inhibitor) and
BMP2/4 receptors (BMPRII, ACVR1, BMPR1A,
BMPR1B) in peri-attachment bovine conceptuses (day
17 of gestation) and CT1 cells, a bovine trophoblast cell
line that produces IFNT but not BNC marker genes
[13,14]. In the second set of studies, CT1 cells were
treated with BMP2 or 4 to explore whether these factors
impact growth, differentiation and gene expression of
these cells.
Methods
Animal use and tissue collection
All animal use was completed with the approval of the
Institutional Animal Care and Use Committee at the
University of Florida. Healthy, non-lactating Holstein
cows (n = 12) were housed at the University of Florida
Dairy Unit (Hague, FL) and fed a diet to meet their
maintenance requirements (mixed ration containing
corn, soybean meal and haylage along with continuous
pasture grazing). Elongated conceptuses were collected
at day 17 post-estrus as described previously [15]. In
brief, cows were superovulated, bred via artificial insemi-
nation and slaughtered by captive bolt trauma and
exsanguination at the University of Florida Meats
Laboratory at day 17 post-estrus. Reproductive tracts
were excised and uterine horns were flushed with Dul-
becco’s phosphate-buffered saline (DPBS; Life Technolo-
gies, Grand Island, NY) to collect conceptuses.
Endometrial samples were collected from non-supero-
vulated cows that were bred and verified pregnant by
the presence of a conceptus as described previously [16],
and RNA was extracted using the Trizol reagent and
PureLink Purification Columns (Life Technologies).
End-point RT-PCR
RNA concentration and integrity were evaluated using a
NanoDrop 2000 Spectrophotometer (Thermo Scientific).
Samples (250 ng/reaction; A260/280 ratio ≥ 1.8) were
incubated in RNase-free DNase (New England Biolabs,
Ipswich, MA) for 30 min at 37°C followed by heat inac-
tivation for 10 min at 75°C. The Superscript III First
Strand Synthesis System (Life Technologies) and ran-
dom hexamers were used for reverse transcription at 50°
C for 60 min. ThermalAce DNA Polymerase (Life Tech-
nologies) was used to amplify DNA (35 cycles; 95°C - 1
min, 55 to 59°C for 1 min [depending on the primer
pair; Table 1], 74°C - 1 min). Non-reverse transcribed
DNase-treated RNA was included as a control for geno-
mic DNA contamination. Amplified products were elec-
trophoresed on a 1% [w/v] agarose gel containing 0.5
μg/ml ethidium bromide and visualized by UV light.
Buffer and residual primers were removed from PCR
Products by using the PureLink PCR Purification Kit
(Life Technologies) and DNA sequencing was completed
at the University of Florida DNA Core Facility.
CT1 culture
The bovine trophectoderm cel ll i n e ,C T 1 ,p r e v i o u s l y
developed and characterized by Talbot et. al [17] was
cultured as described previously [15-17]. In brief, cells
were propagated in Dulbecco’s Modified Eagle’s Medium
(DMEM) with high glucose (5.5 mM) containing 10%
fetal bovine serum and other supplements (100 μM
non-essential amino acids, 2 mM glutamine, 2 mM
sodium pyruvate, 55 μM b-mercaptoethanol, 100 U/ml
penicillin G, 100 μg/ml streptomycin sulfate, and 250
ng/ml amphoterin B; each from Life Technologies) on
Matrigel™ Basement Membrane Matrix (appr. 1 mg/ml;
BD Biosciences, Bedford, MA) at 38.5°C in 5% CO2 in
air. Cells were passaged manually by scraping cells from
the plates and passing them through a small-bore needle
to produce small clumps of cells. On the day before
supplementing BMPs, medium was replaced with med-
ium lacking FBS (serum-free medium) and containing a
serum substitute (ITS; Life Technologies). All other sup-
plements were kept constant. Serum-free medium was
exchanged the next day immediately before adding BMP
treatments. Recombinant human (rh) BMP2 or rhBMP4
(R&D Systems, Minneapolis, MN) was reconstituted
according to manufacturer’s instructions and stored at
Table 1 Primers used for end-point RT-PCR
Gene of Interest Primer Sequence (5’-3’)
BMP2 Forward
Reverse
CTTAGACGGTCTGCGGTCTC
CGAAGCTCTCCCACCTACTG
BMP4 Forward
Reverse
TGAGCCTTTCCAGCAAGTTT
TACGATGAAAGCCCTGATCC
NOG Forward
Reverse
GAACACCCGGACCCTATCTT
ATGGGGTACTGGATGGGAAT
BMPRII Forward
Reverse
AGACTGTTGGGACCAGGATG
GTCTGGCCCACTGAATTGTT
ACVR1 Forward
Reverse
AAATGGGATCGCTGTACGAC
CTGTGAGTCTGGCAGATGGA
BMPR1A Forward
Reverse
CAGGTTCCTGGACTCAGCTC
CACACCACCTCACGCATATC
BMPR1B Forward
Reverse
AGGTCGCTATGGGGAAGTTT
CTCCCAAAGGATGAGTCCAA
ACTB
a Forward
Reverse
CTGTCCCTGTATGCCTCTGG
AGGAAGGAAGGCTGGAAGAG
a[15]
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CT1 cell number assay
CT1 cells were seeded at low confluency (1 × 10
5 cells/
ml) into 24-well Matrigel™ coated plates (1 mg/ml) and
incubated for 48 h to permit cell adherence to the
Matrigel. Serum-free medium containing 0, 0.1, 1, 10, or
100 ng/ml rhBMP2 or rhBMP4 was added to cultures (4
wells/treatment; 3 replicate studies). Forty-eight hours
later the reduction of a tetrazolium compound (MTS)
into a colored formazon product was used to quantify
viable cell numbers. Color intensity at 490 nm was mea-
sured after 30 min incubation (Cell Titer 96 Aqueous
One Solution Cell Proliferation Assay; Promega Corp.,
Madison, WI). Visual assessment at the time of the
MTS treatment indicated that confluency was > 50% in
each replicate study.
Quantitative (q) RT-PCR
RNA concentration and integrity were evaluated, and
samples (10 ng/reaction; A260/280 ratio ≥ 1.8) were incu-
bated in RNase-free DNase (New England Biolabs, Ips-
wich, MA) for 30 min at 37°C followed by heat
inactivation for 10 min at 75°C. Reverse transcription
and TaqMan PCR was completed as described pre-
viously [18] using an IFNT primer-probe set that recog-
nizes all known bovine IFNT isoforms (a MNC-specific
transcript) or a primer-probe set specific for CSH1
(chorionic somatomammotropic hormone; also known
as placental lactogen), a binucleate cell-specific tran-
script [19] (Table 2). Both probes were labeled with a
fluorescent 5’ 6-FAM reporter dye and 3’ TAMRA
quencher (Life Technologies). Reactions also examined
18S RNA abundance (reference control) (18S RNA Con-
trol Reagent Kit, 5’-VIC-labeled probe, Life Technolo-
gies). This reference was chosen based on previous
studies [18] and because its mRNA concentrations were
not impacted by treatments. After an initial activation/
denaturation step (50°C for 2 min; 95°C for 10 min), 40
cycles of a two-step amplification procedure (60°C for 1
min; 95°C for 15 s) was completed using a 7300 Real-
Time PCR System (Applied Biosystems, Life Technolo-
gies). Each RNA sample was analyzed in triplicate. A
DNase-treated RNA not exposed to reverse transcriptase
was included for each sample ensures samples were free
of genomic DNA contamination. The ΔCt method was
used to examine the relative abundance of IFNT and
CSH1 transcripts with that of 18S RNA [18].
Statistical analyses
All analyses were completed by using the General Linear
Model of analysis of variance from the Statistical Analy-
sis System (SAS Institute, Cary, NC). For qRT-PCR ana-
lysis, ΔCT values were used for analyses and data were
graphed by examining fold-effect [15,16]. Results are
presented as arithmetic means ± SEM.
Results and discussion
The first set of studies examined whether the various
components of the BMP2/4 ligand-receptor system were
expressed in elongated conceptuses and CT1 cells. A
single sample of RNA collected from endometria of
pregnant cows was included as a positive control.
Transcripts for BMP2 and BMP4 were readily detect-
able in elongated conceptuses and CT1 cells (Figure
1A). Transcripts for NOG were detected in elongated
conceptuses but were either absent or detected at very
low levels in CT1 cells (Figure 1A). Ectoderm and meso-
derm expression of NOG is evident during gastrulation
in other species [20], therefore it seems likely that the
trophectoderm is not a primary source of NOG.I ti s
interesting that transcripts for NOG could not be ampli-
fied from bovine endometrium (Figure 1A). Transcripts
for NOG also could not be detected in other endome-
trial preparations obtained from cows in early pregnancy
(days 14-17) (data not shown). Transcripts for NOG can
be detected with in situ hybridization in mouse endome-
trium around the time of implantation, but the pattern
of expression is restricted to stroma immediately under-
lying the epithelium [21]. Perhaps too little NOG mRNA
exists in bovine endometrium for suitable amplification
using conventional RT-PCR. Alternatively, perhaps the
cow differs from mice and lacks endometrial NOG
expression.
Transcripts for various BMP2 and 4 receptors sub-
types also were detected in conceptuses and CT1 cells
(Figure 1B). The TGFb receptors are heterodimeric
complexes comprised of two serine/threonine kinase
receptor classes (type I and II). After ligand binding the
type II receptor phosphorylates the type I receptor,
which then initiates Smads and other intracellular trans-
duction systems [22,23]. Bone morphogenetic proteins 2
and 4 interact with two specific type I receptors, termed
BMPR1A (ALK3) and BMPR1B (ALK6), and a single
Table 2 Primer and probe sets used for qRT-PCR
Gene of Interest Primer/
Probe
Sequence (5’-3’)
a
IFNT
b Forward
Reverse
Probe
TGCAGGACAGAAAAGACTTTGGT
CCTGATCCTTCTGGAGCTGG
TTCCTCAGGAGATGGTGGTAGGGCA
CSH1 Forward
Reverse
Probe
GTGGATTTGTGACCTTGTTCGA
CCTGGCACAAGAGTAGATTTGACA
TCCTGCCTGCTCCTGCTGCTGGTA
aEach probe was synthesized with a 6-FAM reporter dye and TAMRA quencher
b[15]
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Page 3 of 7Figure 1 End-point RT-PCR analysis of transcripts for bovine BMP ligands and receptors in the peri-attachment conceptus (day 17
post-insemination), trophoblast cells (CT1) and endometrium (Endo.). After RT-PCR, reactions were electrophoresed in 1% [w/v] agarose
containing ethidium bromide and amplicons were visualized using UV light. Three different conceptus and CT1 RNA preparations were used in
each reaction but only a single endometrium RNA sample collected from cyclic cows at day 17 post-estrus was included. Panel A depicts BMP
ligands and inhibitors. Panel B depicts BMP2/4 receptors. ACTB was included as a positive control.
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genetic protein 2 also reacts with a third type I receptor
subunit termed ACVR1 (ALK2) [26]. Transcripts for
each of these receptor subtypes were detected in elon-
gated conceptuses and endometrium (Figure 1B). The
CT1 cells also contained the receptor machinery needed
to respond to BMP2 and 4, although they appeared to
contain very little BMPR1B. This receptor subtype is not
required for normal placental formation in mice [27].
New roles for BMP4 in trophoblast lineage specifica-
tion have emerged in the past several years. Trophoblast
lineages are generated from human ESCs by BMP4 sup-
plementation [28,29] and trophoblast development from
bovine blastocyst outgrowths is stimulated by BMP4
[11]. However, potential functions for BMP2 and 4 after
trophoblast specification have not been examined in cat-
tle. The first study in this series of experiments exam-
ined whether BMP2 or BMP4 supplementation
influenced CT1 cell growth (Figure 2). Supplementation
with BMP2 did not affect viable cell numbers, but sup-
plementation with 1, 10 or 100 ng/ml BMP4 reduced (P
< 0.05) CT1 cell number after 48 h (Figure 2). Cells
treated with BMP4 did not display any overt micro-
scopic evidence of apoptosis or necrosis (detached, swol-
len/shriveled or punctated cells). Follow-up studies to
quantify apoptosis and proliferation rates were not
completed.
Another set of studies examined whether CT1 cells
underwent any developmental modifications after sup-
plementing serum free medium with 0.1, 1, 10 or 100
ng/ml BMP2 or BMP4. Microscopic examination of
CT1 cells in various studies failed to detect changes in
the incidence of BNC formation (< 2% in all groups;
data not shown). Moreover, CSH1 transcripts could not
be detected in CT1 cells after 48 or 96 h supplementa-
tion with BMP2 or 4 (data not shown). A mid-gestation
placental RNA preparation was used to verify that CSH1
primers worked properly. The lack of detectable changes
in trophoblast morphology and differentiation-depen-
dent gene expression changes suggests that these factors
may not be directly linked with trophoblast differentia-
tion. However, limited effort has been devoted to unco-
vering ways to maximize BNC formation and BNC-
specific gene expression in these cells. Therefore, a pos-
sible association between these BMPs and bovine tro-
phoblast differentiation cannot be dismissed.
A final study determined that exposure to BMP2 or 4
decreased (P < 0.05) the relative abundance of IFNT
mRNA (Figure 3). The minimal effective concentration
needed to achieve this effect was less for BMP2 (10 ng/
ml) than BMP4 (100 ng/ml). Expression of IFNT was
decreased in a dose-dependent manner by BMP2 but
not by BMP4. These outcomes suggest that BMP2 may
be a more potent inhibitor of IFNT expression than
BMP4. Changes in the synthesis and secretion of IFNT
protein were not determined since IFNT mRNA abun-
dance is usually reflective of protein production [16].
Interferon-tau exhibits a biphasic expression pattern
during early pregnancy, where the amounts of IFNT
mRNA increase dramatically around the time of concep-
tus elongation (day 13-15 in cattle) and decrease rapidly
approximately one week later as implantation begins
[30]. Several uterine- and conceptus-derived factors
such as fibroblast growth factors (e.g. FGF2, 10) and col-
ony stimulating factor 2 stimulate IFNT production
from bovine trophectoderm [16,18,31,32]. These and
Figure 2 Effect of BMP2 or BMP4 supplementation on CT1 cell survival. CT1 cells were supplemented with various concentrations of BMP2
(left panel) or BMP4 (right panel) for 48 h, then viable cell numbers were quantified by examining the metabolism a tetrazolium compound
(MTS) into a colored formazon product visible at 490 nm (n = 4 replicate studies for each BMP). Different superscripts within each BMP
treatment denote differences (P < 0.05).
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IFNT production during elongation. The identity of
uterine and conceptus factors functioning as negative
regulators of IFNT expression remained undetermined.
Perhaps BMP2 and 4 may function as implantation-
dependent down regulators of IFNT expression. How-
ever, the magnitude of the reduction in IFNT mRNA
was not great (< 2-fold reduction) and it is not clear
whether the large amounts of BMP supplementation
needed to detect this effect have any physiological
relevance.
In conclusion, ligands and receptors for BMP2 and 4
are expressed in elongating conceptuses and the CT1
cell line. No detectable changes in cell morphology or
differentiation were detected after CT1 exposure to
these BMPs. However, supplementation with BMP2 or 4
decreased cell growth rates and IFNT mRNA abun-
dance. These observations implicate BMP2 and 4 as
uterine and conceptus mediators of trophoblast develop-
ment and IFNT production around the time of
implantation.
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